Oncology & Cancer

Targeted therapies offer hope against aggressive cancer

Several new targeted therapies have shown promise against advanced cancers of the blood, lungs, ovaries, and thyroid, according to research released Saturday at a major US cancer conference.

Oncology & Cancer

Team studies obinutuzumab for treating chronic lymphocytic leukemia

Two North Shore-LIJ Cancer Institute doctors, world-renowned for their research in chronic lymphocytic leukemia (CLL), weigh in on a German study of a new drug therapy for CLL in the March 20 edition of the New England Journal ...

page 11 from 16